Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients

Objective:We evaluated different treatment results reported and showed the effect of treatment at single and multiple clinics for small-cell lung cancer (SCLC). We attempted to show a decreasing impact of chemotherapy (CT) and thoracic radiotherapy (RT) treatment results when implemented at differen...

Full description

Bibliographic Details
Main Authors: Huriye Senay KIZILTAN, Didem TASTEKIN, Ali Hikmet ERIS, Ozgur TASPINAR, Medina ISMAYLOVA, Alpaslan MAYADAGLI
Format: Article
Language:English
Published: Galenos Publishing House 2016-08-01
Series:Bezmiâlem Science
Subjects:
Online Access: http://bezmialemscience.org/archives/archive-detail/article-preview/mportance-of-performing-radiotherapy-and-chemother/20337
id doaj-4bc00741fd0c4142970365ad6d59676f
record_format Article
spelling doaj-4bc00741fd0c4142970365ad6d59676f2020-11-25T00:43:35ZengGalenos Publishing HouseBezmiâlem Science2148-23732148-23732016-08-0142515510.14235/bs.2016.46713049054Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer PatientsHuriye Senay KIZILTAN0Didem TASTEKIN1Ali Hikmet ERIS2Ozgur TASPINAR3Medina ISMAYLOVA4Alpaslan MAYADAGLI5 Department of Radiation Oncology, Bezmialem Vakıf University School of Medicine, İstanbul, Turkey Department of Medical Oncology, Bezmialem Vakıf University School of Medicine, İstanbul, Turkey Department of Radiation Oncology, Bezmialem Vakıf University School of Medicine, İstanbul, Turkey Department Physical Medicine and Rehabilitation, Bezmialem Vakıf University School of Medicine, İstanbul, Turkey Department of Radiation Oncology, Bezmialem Vakıf University School of Medicine, İstanbul, Turkey Department of Radiation Oncology, Bezmialem Vakıf University School of Medicine, İstanbul, Turkey Objective:We evaluated different treatment results reported and showed the effect of treatment at single and multiple clinics for small-cell lung cancer (SCLC). We attempted to show a decreasing impact of chemotherapy (CT) and thoracic radiotherapy (RT) treatment results when implemented at different clinics for SCLC compared to the treatment results at a clinic.Methods:We conducted a retrospective study on 54 non-metastatic SCLC patients who underwent treatments at various clinics. Patients underwent 1–12 courses of CT before they came to the clinic for thoracic RT. RT was performed at 180–400 cGy dose per fraction for a total of 30–52 Gy doses, and patients were followed for 12–60 months.Results:When the study was reviewed, the results showed that the median disease-free survival and survival rates were 8 and 9 months and that the 2-, 5-, and 5-year survival rates were 8%, 6.3%, and 1.8%, respectively. The median progression-free survival rates for 2 and 3 years were 4%, and for 5 years, it was 1.8%. Weight loss for disease-free survival (p=0.01) and superior vena cava syndrome for overall survival (p=0.02) were considered as bad prognostic factors. In this study, acceptable toxicity values were found when the results were compared with those from other studies.Conclusion:We obtained worse results than those from literature data on our SCLC patients who came to our clinic after the progression of their disease. The main causes were identified as insufficient staging and different treatment protocols applied at different clinics. Therefore, we argue that CT and thoracic RT for SCLC must be performed at the same clinic and that the same protocols and staging methods must be used. http://bezmialemscience.org/archives/archive-detail/article-preview/mportance-of-performing-radiotherapy-and-chemother/20337 Small cell lung cancerchemoradiotherapyvena cava syndrome
collection DOAJ
language English
format Article
sources DOAJ
author Huriye Senay KIZILTAN
Didem TASTEKIN
Ali Hikmet ERIS
Ozgur TASPINAR
Medina ISMAYLOVA
Alpaslan MAYADAGLI
spellingShingle Huriye Senay KIZILTAN
Didem TASTEKIN
Ali Hikmet ERIS
Ozgur TASPINAR
Medina ISMAYLOVA
Alpaslan MAYADAGLI
Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients
Bezmiâlem Science
Small cell lung cancer
chemoradiotherapy
vena cava syndrome
author_facet Huriye Senay KIZILTAN
Didem TASTEKIN
Ali Hikmet ERIS
Ozgur TASPINAR
Medina ISMAYLOVA
Alpaslan MAYADAGLI
author_sort Huriye Senay KIZILTAN
title Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients
title_short Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients
title_full Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients
title_fullStr Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients
title_full_unstemmed Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients
title_sort importance of performing radiotherapy and chemotherapy in the same clinic and bad prognostic factors for small-cell lung cancer patients
publisher Galenos Publishing House
series Bezmiâlem Science
issn 2148-2373
2148-2373
publishDate 2016-08-01
description Objective:We evaluated different treatment results reported and showed the effect of treatment at single and multiple clinics for small-cell lung cancer (SCLC). We attempted to show a decreasing impact of chemotherapy (CT) and thoracic radiotherapy (RT) treatment results when implemented at different clinics for SCLC compared to the treatment results at a clinic.Methods:We conducted a retrospective study on 54 non-metastatic SCLC patients who underwent treatments at various clinics. Patients underwent 1–12 courses of CT before they came to the clinic for thoracic RT. RT was performed at 180–400 cGy dose per fraction for a total of 30–52 Gy doses, and patients were followed for 12–60 months.Results:When the study was reviewed, the results showed that the median disease-free survival and survival rates were 8 and 9 months and that the 2-, 5-, and 5-year survival rates were 8%, 6.3%, and 1.8%, respectively. The median progression-free survival rates for 2 and 3 years were 4%, and for 5 years, it was 1.8%. Weight loss for disease-free survival (p=0.01) and superior vena cava syndrome for overall survival (p=0.02) were considered as bad prognostic factors. In this study, acceptable toxicity values were found when the results were compared with those from other studies.Conclusion:We obtained worse results than those from literature data on our SCLC patients who came to our clinic after the progression of their disease. The main causes were identified as insufficient staging and different treatment protocols applied at different clinics. Therefore, we argue that CT and thoracic RT for SCLC must be performed at the same clinic and that the same protocols and staging methods must be used.
topic Small cell lung cancer
chemoradiotherapy
vena cava syndrome
url http://bezmialemscience.org/archives/archive-detail/article-preview/mportance-of-performing-radiotherapy-and-chemother/20337
work_keys_str_mv AT huriyesenaykiziltan importanceofperformingradiotherapyandchemotherapyinthesameclinicandbadprognosticfactorsforsmallcelllungcancerpatients
AT didemtastekin importanceofperformingradiotherapyandchemotherapyinthesameclinicandbadprognosticfactorsforsmallcelllungcancerpatients
AT alihikmeteris importanceofperformingradiotherapyandchemotherapyinthesameclinicandbadprognosticfactorsforsmallcelllungcancerpatients
AT ozgurtaspinar importanceofperformingradiotherapyandchemotherapyinthesameclinicandbadprognosticfactorsforsmallcelllungcancerpatients
AT medinaismaylova importanceofperformingradiotherapyandchemotherapyinthesameclinicandbadprognosticfactorsforsmallcelllungcancerpatients
AT alpaslanmayadagli importanceofperformingradiotherapyandchemotherapyinthesameclinicandbadprognosticfactorsforsmallcelllungcancerpatients
_version_ 1725277597994057728